Godrej Agrovet Limited is a diversified, research and development-focused agri-business company. It operates across five key business verticals, demonstrating a significant presence throughout the agricultural value chain in India. The company is a leader in the Animal Feed segment, producing compound feed for cattle, poultry (broiler and layer), fish, and shrimp. In the Vegetable Oil segment, Godrej Agrovet stands as the largest domestic producer of Crude Palm Oil (CPO) and Palm Kernel Oil (PKO). Its Crop Protection business offers a range of agrochemical products that cater to the entire lifecycle of crops. Through its subsidiary, Astec Lifesciences, the company manufactures a wide variety of agrochemical active ingredients and intermediates for a global market, with capabilities in both enterprise sales and custom development and manufacturing (CDMO). The company also has a strong foothold in the dairy sector through its subsidiary, Creamline Dairy, a private dairy player in Southern India with a diverse product portfolio. Finally, its Poultry & Processed Foods business, under Godrej Foods Limited, is strategically shifting its focus from live birds to higher-margin, value-added branded products. This integrated and diversified model allows Godrej Agrovet to mitigate risks associated with any single agricultural sub-sector and leverage cross-segment synergies.

Official Website: http://www.godrejagrovet.com/

The company has delivered a strong financial performance, primarily driven by revenue growth and margin expansion in its core operations. The analysis below focuses on the underlying business performance, excluding non-recurring items for a clearer view.

• Q3 FY26 Performance (Year-over-Year)

• Revenue: Grew by 11.0% to ₹2,718 Crore from ₹2,450 Crore.

• EBITDA: Increased by 13.6% to ₹260 Crore. The EBITDA margin improved slightly to 9.6% from 9.3%.

• Profit Before Tax (PBT): Showed robust growth of 23.1%, reaching ₹169 Crore compared to ₹138 Crore in the prior year. PBT margin expanded to 6.2% from 5.6%.

• Profit After Tax (PAT): Grew significantly by 33.9% to ₹133 Crore. The PAT margin improved to 4.9% from 4.0%.

• 9M FY26 Performance (Year-over-Year)

• Revenue: Grew by 9.0% to ₹7,900 Crore from ₹7,249 Crore.

• EBITDA: Increased by 11.3% to ₹763 Crore. The EBITDA margin saw a healthy improvement to 9.7% from 9.4%.

• Profit Before Tax (PBT): Grew by a strong 17.3% to ₹482 Crore. PBT margin expanded to 6.1% from 5.7%.

• Profit After Tax (PAT): Grew by 14.5% to ₹366 Crore. The PAT margin improved to 4.6% from 4.4%.

• Segment Contribution (9M FY26)

• Revenue Breakdown: Animal Feed is the largest contributor at 44.7%, followed by Vegetable Oil (21.5%), Dairy (14.5%), Crop Protection (10.7%), and Poultry & Processed Food (7.1%).

• Profit (PBIT) Breakdown: The Vegetable Oil segment is the primary profit driver, contributing 47.9% of total segment profit. Animal Feed follows at 27.9%, and Crop Protection at 19.8%. The Dairy and Poultry segments have smaller profit contributions.

The company's financial results for the quarter and nine-month period show healthy top-line growth complemented by strong operational efficiency, leading to significant expansion in profitability.

Godrej Agrovet's business model possesses several distinct characteristics that provide a competitive edge.

• Diversified Agri-Business Model: The company operates across five different but related segments: Animal Feed, Vegetable Oil, Crop Protection, Dairy, and Poultry. This diversification reduces dependency on any single commodity cycle or weather pattern, providing a natural hedge and ensuring more stable earnings.

• Market Leadership: Godrej Agrovet holds a leadership position in key verticals. It is the largest domestic producer of Crude Palm Oil and a leading player in the compound animal feed industry, giving it scale advantages and pricing power.

• Integrated Value Chain Presence: The company's operations span the agricultural value chain, from inputs (feed, crop protection) to processed goods (dairy products, processed chicken). This integration allows for better control over quality, supply chain efficiencies, and deeper market penetration.

• Focus on R&D and Value-Added Products: The company is actively shifting its portfolio towards higher-margin, value-added products. This is evident in the Poultry business's focus on branded products (salience >80%), the Dairy business's new product launches, and the Animal Feed business's development of state-specific nutritional feeds.

The company's unique position as a diversified market leader with an integrated value chain and a focus on innovation differentiates it from more specialized agricultural players.

The operating environment presents a mix of challenges and opportunities across different agricultural sectors.

• Adverse Weather Impact: The Crop Protection business was negatively affected by extreme weather events, unseasonal rains, and cyclones in key geographies. This highlights the inherent vulnerability of the agrochemical sector to climatic conditions, which can disrupt planting seasons and reduce demand for crop inputs.

• Commodity Price Volatility: The Dairy business is facing significant headwinds from higher milk procurement prices. This industry-wide issue is compressing margins for dairy players, as passing on the full extent of cost increases to consumers can be challenging.

• Favorable Palm Oil Dynamics: The Vegetable Oil business is benefiting from strong growth in Fresh Fruit Bunch (FFB) arrivals, which grew by 16% YoY. This suggests favorable agronomic conditions and supportive government policies for palm cultivation are creating a positive outlook for domestic palm oil producers.

The industry is navigating climatic challenges and input cost inflation, but segments with strong underlying volume growth, like palm oil, continue to show a positive outlook.

The company's growth is being driven by strong performance in its core segments, supported by both volume expansion and improved operational efficiency.

• Animal Feed Volume Growth: This segment saw a robust 12% YoY increase in sales volume in Q3 FY26, reaching 445,060 MT. The growth was primarily led by a significant 21% YoY increase in cattle feed volumes, indicating strong demand and market share gains.

• Vegetable Oil Expansion: The segment's revenue grew by a healthy 27% YoY in Q3 FY26. This was driven by a 16% growth in Fresh Fruit Bunch (FFB) volumes and a 30 bps improvement in the Oil Extraction Ratio (OER), leading to higher production of end-products.

• Astec Lifesciences Turnaround: The subsidiary showed a significant performance improvement, with revenues growing 32.9% YoY in Q3 FY26. It achieved a positive EBITDA of ₹5 Crore, a sharp turnaround from a loss of ₹4 Crore in the previous year, driven by robust volume growth in both its enterprise and CDMO categories.

• Profitability Drivers: Overall PBT (before non-recurring items) grew by an impressive 23.1% in Q3 FY26. This was fueled by a 17% YoY improvement in the underlying segment result for Animal Feed and a 25% YoY growth in the segment result for Vegetable Oil.

Growth is being powered by fundamental volume increases in the Animal Feed and Vegetable Oil businesses, coupled with a strong operational turnaround at Astec Lifesciences.

Godrej Agrovet is actively pursuing growth through strategic new product development and market expansion initiatives.

• New Product Development (NPD) in Animal Feed: The company is leveraging NPD to cater to state-specific nutritional requirements. It launched "Dhanalaxmi G," a premium cattle feed in Western India, and "Bypro Plus," an improved formulation in Southern India, both of which have received a positive market response.

• Portfolio Expansion in Crop Protection: The company is strengthening its presence in key crops. It launched "Ashitaka" (maize herbicide) in July 2025 and is planning to launch "Takai" (paddy insecticide) in Q4 FY26 to target the Rabi paddy market.

• Market Penetration in Dairy: The Dairy business launched a ₹99 paneer pack specifically for quick-commerce channels to drive penetration and a ₹20 Badam Milk to democratize the category. These launches target new price points and distribution channels to expand the consumer base.

• International Market Access for Astec: Astec Lifesciences is unlocking new growth markets. It received product registrations for Cyproconazole & Tebuconazole in Brazil and European equivalence for Metconazole, opening up significant export opportunities.

The company is capitalizing on opportunities by launching targeted new products, entering new crop segments, and gaining access to new international markets.

The company has outlined clear plans to build upon its recent successes and expand its market reach.

• Geographic Expansion of New Products: Following the successful launch of its new premium cattle feed products in select regions, the company plans to roll them out in other geographies to build a strong national volume base.

• Targeting Key Agricultural Seasons: The planned Q4 launch of the "Takai" insecticide is strategically timed to target the Rabi paddy season, demonstrating a proactive approach to capturing seasonal demand.

• Driving Distribution with New SKUs: The launch of the ₹99 paneer pack is not just for Q-commerce but is also intended to be used as a tool to drive distribution expansion in general trade channels.

Future plans are focused on scaling up successful new product launches across wider geographies and strategically timing market entries to maximize impact.

Margin performance was mixed across segments, with operational efficiencies in some businesses offsetting cost pressures in others.

• Consolidated Margin Expansion: At the consolidated level, EBITDA margin improved to 9.6% from 9.3% YoY in Q3 FY26. PBT margin saw a more significant expansion, rising to 6.2% from 5.6%, indicating better operational leverage.

• Animal Feed Margin Improvement: The underlying segment margin for Animal Feed improved to 6.9% from 6.0% YoY in Q3 FY26. This was a result of operational efficiencies and cost management initiatives, with EBIT/MT growing by ~4% to ₹2,020/MT.

• Vegetable Oil Margin Stability: This segment maintained strong and stable margins, reporting a segment margin of 23.4% in Q3 FY26, nearly flat compared to 23.7% in the previous year, despite lower CPO realizations.

• Crop Protection Margin Contraction: The segment margin was flat YoY as lower volumes in high-margin in-licensing and in-house categories, impacted by weather, offset the benefit of higher generic sales. For the 9M period, the margin contracted to 32.6% from 41.6%.

• Dairy Margin Under Pressure: The EBITDA margin for the Creamline Dairy business was adversely impacted, falling to 3.0% in Q3 FY26 from 4.9% a year ago. This was a direct result of higher milk procurement prices and a revenue shortfall.

• Poultry & Processed Food Margin Growth: Godrej Foods saw its EBITDA margin expand significantly to 7.9% from 5.2% YoY. This was driven by higher contribution margins from its branded products and better live bird prices.

Overall profitability improved due to strong margin performance in the Animal Feed, Vegetable Oil, and Poultry segments, which successfully countered margin compression in the Dairy and Crop Protection businesses.

The company's performance is subject to several external factors and industry-specific challenges.

• Climatic Risks: The performance of the Crop Protection business is highly dependent on weather conditions. As seen in Q3, extreme weather events, unseasonal rains, and cyclones can severely impact demand for agrochemicals by disrupting cropping patterns.

• Input Cost Volatility: The Dairy business is exposed to fluctuations in raw material prices, particularly milk. The sharp increase in milk procurement prices directly squeezed EBITDA margins, highlighting the risk of cost-push inflation in this segment.

• Product Mix Impact: In the Animal Feed segment, revenue growth was muted at 2% despite a 12% volume increase. This was due to a change in product mix leading to lower average price realizations, demonstrating a risk to top-line growth even with strong volumes.

• Live Bird Price Fluctuation: While the Poultry segment benefited from better live bird prices in Q3, this market is notoriously cyclical. A downturn in live bird prices could negatively impact the segment's profitability in the future.

The primary risks stem from weather volatility impacting the crop business and commodity price inflation pressuring margins in the dairy segment.

• Strategic Shift in Poultry: The Poultry & Processed Food business (Godrej Foods) is successfully executing its strategy to de-emphasize live bird sales and focus on value-added products. Branded product salience increased to ~81% in Q3 FY26 from ~77% a year ago.

• Sustainability Leadership: The company continues to strengthen its ESG profile. Astec Lifesciences received a "Gold" rating from EcoVadis, placing it in the top quartile of global companies for sustainability. Godrej Agrovet also received a leadership "A-" rating from CDP for climate and forest disclosures.

• Commitment to Emission Reduction: The company is the first in the Indian agri-sector to have an approved science-based emission reduction target. It aims for a 37.5% reduction in Scope 1+2 GHG emissions by FY35 from an FY20 baseline.

• Shareholding Structure: As of December 31, 2025, the Promoters hold a 67.7% stake in the company. Institutional investors have a significant holding, with Foreign Institutional Investors (FIIs) at 6.3% and Domestic Institutional Investors (DIIs) at 7.0%. Key investors include Temasek, LIC, and Nippon Mutual Fund.

The company is making tangible progress on its strategic and ESG objectives, which is being recognized by global rating agencies and reflected in a strong institutional shareholding.